Retrovirology

ISSNs: , 1742-4690

References in Retrovirology:

Search this table:

Title	Authors	Year
Retroviral superinfection resistance.	Nethe M, Berkhout B, van der Kuyl AC	2005
Aggressive HIV-1?	Berkhout B, de Ronde A, van der Hoek L	2005
A historical reflection on the discovery of human retroviruses.	Vahlne A	2009
The mutation T477A in HIV-1 reverse transcriptase (RT) restores normal proteolytic processing of RT in virus with Gag-Pol mutated in the p51-RNH cleavage site.	Abram ME, Sarafianos SG, Parniak MA	2010
It's the virus, stupid--part 2.	Berkhout B	2005
A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants.	Johnson BC, Pauly GT, Rai G, Patel D, Bauman JD, Baker HL, Das K, Schneider JP, Maloney DJ, Arnold E, Thomas CJ, Hughes SH	2012
Effects of the K65R and K65R/M184V reverse transcriptase mutations in subtype C HIV on enzyme function and drug resistance.	Xu HT, Martinez-Cajas JL, Ntemgwa ML, Coutsinos D, Frankel FA, Brenner BG, Wainberg MA	2009
Comparative biochemical analysis of recombinant reverse transcriptase enzymes of HIV-1 subtype B and subtype C.	Xu HT, Quan Y, Asahchop EL, Oliveira M, Moisi D, Wainberg MA	2010
Higher levels of Zidovudine resistant HIV in the colon compared to blood and other gastrointestinal compartments in HIV infection.	van Marle G, Church DL, Nunweiler KD, Cannon K, Wainberg MA, Gill MJ	2010
Hypersusceptibility mechanism of Tenofovir-resistant HIV to EFdA.	Michailidis E, Ryan EM, Hachiya A, Kirby KA, Marchand B, Leslie MD, Huber AD, Ong YT, Jackson JC, Singh K, Kodama EN, Mitsuya H, Parniak MA, Sarafianos SG	2013
Evolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: from treatment to prevention.	Gupta RK, Van de Vijver DA, Manicklal S, Wainberg MA	2013

Showing 1 to 11 of 11 entries

Version:20250422